glp 1/gip agonist GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know Bridging the gap between GLP1-receptor
Description
After 56 weeks of treatment, the average weight loss of the patients was 8.40 7.3 kg, and the most common adverse reactions were mild or moderate nausea and diarrhea
Ren, G., Xue, P., Wu, B., Yang, F
10.1016/j.cmet.2017.04.013 27 GreinerT
Eliaschewitz, F
Journal of cellular and molecular medicine
GLP-1 agonists for obesityA new recipe for success
